Altered levels of CHIT1 in the CSF have been shown as a biomarker for other neurodegenerative disorders, such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (41–43). This evidence concerns the gene CHIT1 and amyotrophic lateral sclerosis.